{"AllianceGenome": "3973", "HGNC": "3973", "MIM": "605343", "_id": "10272", "_version": 1, "accession": {"genomic": ["AC004156.1", "AC112708.3", "CH471242.1", "CP068259.2", "NC_000019.10", "NC_060943.1"], "protein": ["AAC64321.1", "AAH05839.1", "AAQ89276.1", "BAF84647.1", "EAW61165.1", "EAW61166.1", "NP_005851.1", "O95633.1"], "rna": ["AK291958.1", "AK311521.1", "AK311566.1", "AK313341.1", "AL050194.1", "AY358917.1", "BC005839.2", "BC033119.1", "BQ319646.1", "BX439786.2", "NM_005860.3", "U76702.1"], "translation": [{"protein": "AAH05839.1", "rna": "BC005839.2"}, {"protein": "AAC64321.1", "rna": "U76702.1"}, {"protein": "AAQ89276.1", "rna": "AY358917.1"}, {"protein": "NP_005851.1", "rna": "NM_005860.3"}, {"protein": "BAF84647.1", "rna": "AK291958.1"}]}, "alias": ["FLRG", "FSRP"], "ensembl": {"gene": "ENSG00000070404", "protein": ["ENSP00000166139", "ENSP00000466383", "ENSP00000477770", "ENSP00000483064", "ENSP00000484376", "ENSP00000484412"], "transcript": ["ENST00000166139", "ENST00000588773", "ENST00000589185", "ENST00000591573", "ENST00000592058", "ENST00000592947", "ENST00000605925"], "translation": [{"protein": "ENSP00000166139", "rna": "ENST00000166139"}, {"protein": "ENSP00000484376", "rna": "ENST00000589185"}, {"protein": "ENSP00000483064", "rna": "ENST00000592947"}, {"protein": "ENSP00000466383", "rna": "ENST00000588773"}, {"protein": "ENSP00000477770", "rna": "ENST00000591573"}, {"protein": "ENSP00000484412", "rna": "ENST00000605925"}], "type_of_gene": "protein_coding"}, "entrezgene": "10272", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 4.97052800062, "exp_mis": 74.3029285679, "exp_syn": 41.1994885321, "lof_z": 1.76415484788886, "mis_z": 1.37902498059965, "mu_lof": 6.08609259441e-07, "mu_mis": 1.50028045804e-05, "mu_syn": 8.1832030392e-06, "n_lof": 1.0, "n_mis": 50.0, "n_syn": 40.0, "p_li": 0.418831972518919, "p_null": 0.0347421328285287, "p_rec": 0.546425894652553, "syn_z": 0.11585110935163}, "bp": 792, "cds_end": 681708, "cds_start": 676423, "n_exons": 5, "nonpsych": {"exp_lof": 4.44378242912, "exp_mis": 67.1962972773, "exp_syn": 37.2344889445, "lof_z": 1.60439495583799, "mis_z": 1.24268430360538, "mu_lof": 6.08609259441e-07, "mu_mis": 1.50028045804e-05, "mu_syn": 8.1832030392e-06, "n_lof": 1.0, "n_mis": 47.0, "n_syn": 38.0, "p_li": 0.399267557694111, "p_null": 0.0468938676649264, "p_rec": 0.553838574640962, "syn_z": -0.0789844715577605}, "nontcga": {"exp_lof": 4.56752241739, "exp_mis": 68.3533357646, "exp_syn": 37.8981688791, "lof_z": 1.64667380932234, "mis_z": 1.34701461882203, "mu_lof": 6.08609259441e-07, "mu_mis": 1.50028045804e-05, "mu_syn": 8.1832030392e-06, "n_lof": 1.0, "n_mis": 46.0, "n_syn": 37.0, "p_li": 0.389938358049404, "p_null": 0.0421960165321841, "p_rec": 0.567865625418412, "syn_z": 0.0923786632838819}, "transcript": "ENST00000166139.4"}, "exons": [{"cdsend": 681708, "cdsstart": 676423, "chr": "19", "position": [[676391, 676526], [677791, 677977], [680273, 680489], [681332, 681560], [681649, 683385]], "strand": 1, "transcript": "NM_005860", "txend": 683385, "txstart": 676391}], "exons_hg19": [{"cdsend": 681708, "cdsstart": 676423, "chr": "19", "position": [[676391, 676526], [677791, 677977], [680273, 680489], [681332, 681560], [681649, 683385]], "strand": 1, "transcript": "NM_005860", "txend": 683385, "txstart": 676391}], "generif": [{"pubmed": 11948405, "text": "Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function"}, {"pubmed": 12397211, "text": "our present data suggest that protein kinase C and A signal transduction pathways differently regulate the expression of FLRG in human ovarian granulosa-luteal cells"}, {"pubmed": 12531697, "text": "Follistatin and FLRG proteins downmodulate the effects of activin A and BMP2 on erythroid maturation."}, {"pubmed": 14739256, "text": "likely to be a local regulator of activin action in gonadal development and gametogenesis"}, {"pubmed": 15130517, "text": "Data report the endometrial mRNA and peptide expression of follistatin-related gene (FLRG), a protein that binds activin-A, preventing its interaction."}, {"pubmed": 15451575, "text": "review discusses differences between signal targets of follistatin and FLRG and distinct functions and mechanisms for these two proteins in the human hematopoietic system"}, {"pubmed": 16150905, "text": "comparison of the kinetics of FST isoform and FSTL3 biosynthesis, trafficking, and secretion"}, {"pubmed": 16338475, "text": "IGFBP1 and Follistatin-like 3 are highly up-regulated in intrauterine growth restriction in the placenta."}, {"pubmed": 16627583, "text": "the differential biological actions among the FST isoforms and FSTL3 are primarily dependent on their relative cell-surface binding ability and ligand specificity"}, {"pubmed": 16935389, "text": "Follistatin-like 3 expression was low in normal but enhanced in malignant rat liver. in human normal liver, in contrast, it was abundantly expressed but downregulated in liver cancer"}, {"pubmed": 17296189, "text": "Ovarian endometriotic lesions show a deranged expression of activin A-binding proteins FLRG and follistatin, which may result in an altered effect of activin A on angiogenesis and/or endometrial differentiation."}, {"pubmed": 17395406, "text": "TNFalpha activates FLRG expression at the transcriptional level."}, {"pubmed": 17671190, "text": "Overexpression of FLRG, an antagonist of activin is associated with increased breast tumor cell growth"}, {"pubmed": 17868029, "text": "Data show that the nuclear isoform of FLRG lacks an intrinsic transactivation domain, but enhances AF10-mediated transcription, probably through promoting the homo-oligomerization of AF10, thus facilitating the recruitment of co-activators."}, {"pubmed": 17959243, "text": "Hypoxia enhances the expression of FSTL3 and its release from PHT cells."}, {"pubmed": 18617621, "text": "Elevated myocardial expression of FST-like genes is a feature of heart failure, and may be linked to both disease severity and mechanisms underlying recovery."}, {"pubmed": 18768470, "text": "analysis of the structure of the FSTL3.activin A complex"}, {"pubmed": 19740438, "text": "FLRG expression was regulated in the epithelial cytoplasm and nucleus of the malignant breast tissue."}, {"pubmed": 20007937, "text": "First-trimester FSTL3 levels are associated with glucose intolerance and gestational diabetes later in pregnancy."}, {"pubmed": 20063262, "text": "FLRG can be successfully detected in maternal plasma in the first trimester of pregnancy but its levels are not significantly altered in the presence of Down syndrome fetuses."}, {"pubmed": 21829661, "text": "GDF9 decreases basal and activin A-induced FST and FSTL3 expression, and this explains, in part, its enhancing effects on activin A-induced inhibin beta(B)-subunit mRNA expression and inhibin B production in hGL cells"}, {"pubmed": 22052913, "text": "Structure of myostatin.follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding."}, {"pubmed": 22122995, "text": "Maternal and placental FSTL3 concentrations were reduced in GDM women compared with normally pregnant women, suggesting FSTL3 may play an important role in the pathogenesis of gestational diabetes"}, {"pubmed": 22395277, "text": "After eccentric exercise, postmenopausal women not using hormone therapy (HT) expressed higher levels of follistatin-like protein 3 while postmenopausal women using HT showed a significant increased expression over controls."}, {"pubmed": 22476926, "text": "Resistance exercise resulted in a significant downregulation of MSTN and FBXO32 mRNA expression and a significant upregulation in FSTL3 and SMURF1 mRNA expression, and carbohydrate and protein feeding have little influence on the these markers expression."}, {"pubmed": 22568578, "text": "Data suggest that serum levels of FSTL3 are higher in pre-eclampsia than in controls; placental expression of FSTL3 is also increased in pre-eclampsia compared with controls; no differences were observed between mild and severe pre-eclampsia."}, {"pubmed": 22915069, "text": "Suggest FSTL3 has a role in paracrine communication between cardiomyocytes and fibroblasts."}, {"pubmed": 24475769, "text": "The elevation of Follistatin-like-3 was demonstrated in late second trimester of pregnancy destined to developing preeclampsia, suggesting its causal role in the pathogenesis and prediction of preeclampsia."}, {"pubmed": 24700053, "text": "Elevated FSTL-3 concentrations were attributable to preeclampsia and were associated with increased likelihood of later developing preeclampsia, suggesting further study as a biomarker prior to clinically evident disease."}, {"pubmed": 25937185, "text": "FSTL3 is a critical mediator of exercise-dependent bone formation"}, {"pubmed": 26898119, "text": "The serum levels of IL-8, MIP-1 alpha, MIP-1 beta, MMP-8, Resistin, FLRG, and BCAM were significantly higher in breast cancer patients, but LAP and TSH-beta levels were lower."}, {"pubmed": 27623975, "text": "first trimester maternal serum levels not altered in women who develop gestational diabetes mellitus"}, {"pubmed": 28178680, "text": "FSTL3 expression in invasive breast cancer is inversely associated with tumor size and nuclear grade but it does not predict disease relapse in the short term."}, {"pubmed": 28339962, "text": "Human renal dysfunction is the strongest independent predictor of FSTL3 serum concentrations in multivariate analyses."}, {"pubmed": 29394092, "text": "deficient FSTL3 expression by asthmatic Bronchial epithelial cells impairs epithelial regulation of human lung fibroblast and fibroblast-to-myofibroblast transition."}, {"pubmed": 30454705, "text": "Aberrant expression of FSTL3 in preeclampsia led to the dysfunction of trophoblast, indicating its involvement in the pathogenesis of preeclampsia."}, {"pubmed": 31810141, "text": "FSTL3 plays a biological role in the establishment and maintenance of normal pregnancy."}, {"pubmed": 31990347, "text": "Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies."}, {"pubmed": 32543143, "text": "[Expression Level of FLRG in Colon Cancer Tissue and Its Clinical Significance]."}, {"pubmed": 34335633, "text": "Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer."}, {"pubmed": 34425560, "text": "Regulation of follistatin-like 3 expression by miR-486-5p modulates gastric cancer cell proliferation, migration and tumor progression."}, {"pubmed": 36502285, "text": "FSTL3 is highly expressed in adipose tissue of individuals with overweight or obesity and is associated with inflammation."}, {"pubmed": 36807490, "text": "The cytoplasmic expression of FSTL3 correlates with colorectal cancer progression, metastasis status and prognosis."}, {"pubmed": 37739334, "text": "Follistatin and follistatin-like 3 in metabolic disorders."}, {"pubmed": 37751246, "text": "Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study."}, {"pubmed": 37904173, "text": "FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus."}, {"pubmed": 38044354, "text": "Stroma-associated FSTL3 is a factor of calcium channel-derived tumor fibrosis."}], "genomic_pos": {"chr": "19", "end": 683392, "ensemblgene": "ENSG00000070404", "start": 676392, "strand": 1}, "genomic_pos_hg19": {"chr": "19", "end": 683385, "start": 676392, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001503", "qualifier": "involved_in", "term": "ossification"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0002244", "pubmed": 15451575, "qualifier": "involved_in", "term": "hematopoietic progenitor cell differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006357", "pubmed": 11948405, "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007275", "qualifier": "involved_in", "term": "multicellular organism development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0022409", "pubmed": 16336961, "qualifier": "involved_in", "term": "positive regulation of cell-cell adhesion"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030510", "qualifier": "involved_in", "term": "regulation of BMP signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030514", "pubmed": 17878677, "qualifier": "involved_in", "term": "negative regulation of BMP signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0032926", "qualifier": "involved_in", "term": "negative regulation of activin receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032926", "pubmed": [11948405, 12697670], "qualifier": "involved_in", "term": "negative regulation of activin receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045671", "pubmed": 15574124, "qualifier": "involved_in", "term": "negative regulation of osteoclast differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 17868029, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0090101", "pubmed": 17878677, "qualifier": "involved_in", "term": "negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005576", "qualifier": "is_active_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 16150905, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 16150905, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005788", "qualifier": "located_in", "term": "endoplasmic reticulum lumen"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0001968", "pubmed": 16336961, "qualifier": "enables", "term": "fibronectin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [15574124, 17868029, 17878677], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0048185", "qualifier": "enables", "term": "activin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0048185", "pubmed": 12697670, "qualifier": "enables", "term": "activin binding"}]}, "homologene": {"genes": [[7955, 557352], [8364, 548587], [9031, 770427], [9544, 721100], [9598, 455531], [9606, 10272], [9615, 612399], [9913, 515367], [10090, 83554], [10116, 114031]], "id": 4280}, "interpro": [{"desc": "Kazal domain", "id": "IPR002350", "short_desc": "Kazal_dom"}, {"desc": "Follistatin-like, N-terminal", "id": "IPR003645", "short_desc": "Fol_N"}, {"desc": "Kazal domain superfamily", "id": "IPR036058", "short_desc": "Kazal_dom_sf"}, {"desc": "Follistatin/Osteonectin EGF domain", "id": "IPR015369", "short_desc": "Follistatin/Osteonectin_EGF"}, {"desc": "TB domain", "id": "IPR017878", "short_desc": "TB_dom"}, {"desc": "TGF-beta binding (TB) domain superfamily", "id": "IPR036773", "short_desc": "TB_dom_sf"}], "ipi": ["IPI00025155", "IPI00955041"], "map_location": "19p13.3", "name": "follistatin like 3", "other_names": ["follistatin-like 3 (secreted glycoprotein)", "follistatin-like protein 3", "follistatin-related gene protein", "follistatin-related protein 3"], "pantherdb": {"HGNC": "3973", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1890391", "ortholog_type": "LDO", "panther_family": "PTHR10913", "taxid": 10090, "uniprot_kb": "Q9EQC7"}, {"RGD": "621811", "ortholog_type": "LDO", "panther_family": "PTHR10913", "taxid": 10116, "uniprot_kb": "Q99PW7"}, {"Ensembl": "ENSGALG00000042356", "ortholog_type": "LDO", "panther_family": "PTHR10913", "taxid": 9031, "uniprot_kb": "A0A3Q3AWK4"}, {"ZFIN": "ZDB-GENE-050913-111", "ortholog_type": "LDO", "panther_family": "PTHR10913", "taxid": 7955, "uniprot_kb": "A4IG14"}], "uniprot_kb": "O95633"}, "pathway": {"reactome": [{"id": "R-HSA-1502540", "name": "Signaling by Activin"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-2473224", "name": "Antagonism of Activin by Follistatin"}, {"id": "R-HSA-381426", "name": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-8957275", "name": "Post-translational protein phosphorylation"}, {"id": "R-HSA-9006936", "name": "Signaling by TGFB family members"}]}, "pdb": ["2KCX", "3B4V", "3SEK"], "pfam": ["PF07648", "PF09289", "PF21333"], "pharmgkb": "PA28390", "pharos": {"target_id": 18697, "tdl": "Tbio"}, "prosite": ["PS51364", "PS51465"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF169450", "relationship": "is"}, {"id": "GNF180356", "relationship": "is"}, {"id": "GNF191262", "relationship": "is"}, {"id": "GNF202168", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF050392", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF005517", "relationship": "is"}, {"id": "GNF005518", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF284560", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF335974", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF105143", "relationship": "is"}, {"id": "GNF144790", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1"], "protein": "NP_005851.1", "rna": "NM_005860.3", "translation": {"protein": "NP_005851.1", "rna": "NM_005860.3"}}, "reporter": {"HG-U133_Plus_2": "203592_s_at", "HG-U95Av2": "33900_at", "HTA-2_0": "TC19000012.hg.1", "HuEx-1_0": "3815097", "HuGene-1_1": "8023995", "HuGene-2_1": "16856232"}, "summary": "Follistatin-like 3 is a secreted glycoprotein of the follistatin-module-protein family. It may have a role in leukemogenesis. [provided by RefSeq, Jul 2008].", "symbol": "FSTL3", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1333581"}, "unigene": "Hs.529038", "uniprot": {"Swiss-Prot": "O95633", "TrEMBL": ["A0A087WTD3", "K7EM71", "A0A087X1Q2"]}, "wikipedia": {"url_stub": "FSTL3"}}